Unknown

Dataset Information

0

Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid Leukemia.

ABSTRACT:

SUBMITTER: Alfayez M 

PROVIDER: S-EPMC6448807 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
| S-EPMC6238377 | biostudies-literature
Unknown Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
| S-EPMC7797573 | biostudies-literature
Unknown Heterogeneity in refractory acute myeloid leukemia.
| S-EPMC6535032 | biostudies-literature
Unknown ¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
| S-EPMC3186319 | biostudies-literature
Unknown Emerging Immunotherapy for Acute Myeloid Leukemia.
| S-EPMC7920435 | biostudies-literature
Unknown Treatment for Relapsed/Refractory Acute Myeloid Leukemia.
| S-EPMC8171365 | biostudies-literature
Unknown A Heart Murmur Is Discovered on an Oncology Ward: Extramedullary Acute Myeloid Leukemia.
| S-EPMC7811184 | biostudies-literature
Unknown Recent developments in immunotherapy of acute myeloid leukemia.
| S-EPMC5526264 | biostudies-literature
Unknown Opportunities for immunotherapy in childhood acute myeloid leukemia.
| S-EPMC6913480 | biostudies-literature
Unknown Immunotherapy in Acute Myeloid Leukemia: Where We Stand.
| S-EPMC8143531 | biostudies-literature